Pathogenesis and novel therapeutics of regulatory T cell subsets and interleukin-2 therapy in systemic lupus erythematosus

被引：12

作者：

Tsai, Yi-Giien ^{[1
,2
,3
,4
]}

Liao, Pei-Fen ^{[3
,5
]}

Hsiao, Kai-Hung ^{[6
]}

Wu, Hung-Ming ^{[7
]}

Lin, Ching-Yuang ^{[8
]}

Yang, Kuender D. ^{[9
,10
]}

机构：

[1] Changhua Christian Childrens Hosp, Dept Pediat, Changhua, Taiwan

[2] Kaohsiung Med Univ, Sch Med, Kaohsiung 807, Kaohsiung, Taiwan

[3] Chung Shan Med Univ, Sch Med, Taichung, Taiwan

[4] Natl Chung Hsing Univ, Coll Med, Dept Postbaccalaureate Med, Taichung, Taiwan

[5] Chung Shan Med Univ Hosp, Dept Pediat, Div Allergy Asthma & Rheumatol, Taichung, Taiwan

[6] Changhua Christian Hosp, Dept Allergy Immunol & Rheumatol, Changhua, Taiwan

[7] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan

[8] China Med Univ Hosp, Childrens Hosp, Div Pediat Nephrol, Taichung, Taiwan

[9] MacKay Mem Hosp, Dept Pathol, New Taipei City, Taiwan

[10] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan

来源：

FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷

关键词：

systemic lupus erythematosus; lupus nephritis; regulatory T cells; interleukin-2; B regulatory cells; LOW-DOSE IL-2; B-CELLS; DISEASE-ACTIVITY; CD4(+); ACTIVATION; FOXP3; DIFFERENTIATION; SUPPRESSION; ASSOCIATION; CAPACITY;

D O I：

10.3389/fimmu.2023.1230264

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Systemic lupus erythematosus (SLE) is a heterogeneous multisystem inflammatory disease with wide variability in clinical manifestations. Natural arising CD4+ regulatory T cells (Tregs) play a critical role in maintaining peripheral tolerance by suppressing inflammation and preventing autoimmune responses in SLE. Additionally, CD8+ regulatory T cells, type 1 regulatory T cells (Tr1), and B regulatory cells also have a less well-defined role in the pathogenesis of SLE. Elucidation of the roles of various Treg subsets dedicated to immune homeostasis will provide a novel therapeutic approach that governs immune tolerance for the remission of active lupus. Diminished interleukin (IL)-2 production is associated with a depleted Treg cell population, and its reversibility by IL-2 therapy provides important reasons for the treatment of lupus. This review focuses on the pathogenesis and new therapeutics of human Treg subsets and low-dose IL-2 therapy in clinical benefits with SLE.

引用

页数：13

共 125 条

[1] Human regulatory B cells control the TFH cell response [J].

Achour, Achouak ;

Simon, Quentin ;

Mohr, Audrey ;

Seite, Jean-Francois ;

Youinou, Pierre ;

Bendaoud, Boutahar ;

Ghedira, Ibtissem ;

Pers, Jacques-Olivier ;

Jamin, Christophe .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 140 (01) :215-222

[2] Low-dose interleukin-2 therapy: a promising targeted therapeutic approach for systemic lupus erythematosus [J].

Akbarzadeh, Reza ;

Riemekasten, Gabriela ;

Humrich, Jens Y. .

CURRENT OPINION IN RHEUMATOLOGY, 2023, 35 (02) :98-106

[3] The role of complement regulatory proteins in peripheral blood cells of patients with systemic lupus erythematosus: Review [J].

Alegretti, Ana Paula ;

Schneider, Laiana ;

Piccoli, Amanda Kirchner ;

Xavier, Ricardo Machado .

CELLULAR IMMUNOLOGY, 2012, 277 (1-2) :1-7

[4] A Review of Lupus Nephritis [J].

Alforaih, Noura ;

Whittall-Garcia, Laura ;

Touma, Zahi .

JOURNAL OF APPLIED LABORATORY MEDICINE, 2022, 7 (06) :1450-1467

[5]

Ali Hanaa N, 2022, Prague Med Rep, V123, P166, DOI 10.14712/23362936.2022.15

[6] Impaired granzyme B-producing regulatory B cells in systemic lupus erythematosus [J].

Bai, Mingxin ;

Xu, Liling ;

Zhu, Huaqun ;

Xue, Jimeng ;

Liu, Tian ;

Sun, Feng ;

Yao, Haihong ;

Zhao, Zhen ;

Wang, Ziye ;

Yao, Ranran ;

Hu, Fanlei ;

Su, Yin .

MOLECULAR IMMUNOLOGY, 2021, 140 :217-224

[7] Mechanisms of action of low-dose IL-2 restoration therapies in SLE [J].

Ballesteros-Tato, Andre ;

Papillion, Amber .

CURRENT OPINION IN IMMUNOLOGY, 2019, 61 :39-45

[8] CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients [J].

Blair, Paul A. ;

Norena, Lina Yassin ;

Flores-Borja, Fabian ;

Rawlings, David J. ;

Isenberg, David A. ;

Ehrenstein, Michael R. ;

Mauri, Claudia .

IMMUNITY, 2010, 32 (01) :129-140

[9] Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFNa and B cell subsets [J].

Bradford, Hannah F. ;

Haljasmagi, Liis ;

Menon, Madhvi ;

McDonnell, Thomas C. R. ;

Sarekannu, Karita ;

Vanker, Martti ;

Peterson, Part ;

Wincup, Chris ;

Abida, Rym ;

Gonzalez, Raquel Fernandez ;

Bondet, Vincent ;

Duffy, Darragh ;

Isenberg, David A. ;

Kisand, Kai ;

Mauri, Claudia .

CELL REPORTS MEDICINE, 2023, 4 (01)

[10] IL-2 receptor β-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells [J].

Burchill, Matthew A. ;

Yang, Jianying ;

Vogtenhuber, Christine ;

Blazar, Bruce R. ;

Farrar, Michael A. .

JOURNAL OF IMMUNOLOGY, 2007, 178 (01) :280-290

← 1 2 3 4 5 6 7 8 9 10 →